Pharma Reaserch Prod Co Ltd (214450) — Strategic Asset Allocation Index
Pharma Reaserch Prod Co Ltd (214450) has a Strategic Asset Allocation Index of 28.2% as of March 2025. Strategic assets (PP&E of ₩159.08 Billion plus long-term investments of ₩-) total ₩159.08 Billion, measured against net assets of ₩564.31 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of Pharma Reaserch Prod Co Ltd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Pharma Reaserch Prod Co Ltd Strategic Asset Allocation Index (2015–2024)
This chart shows how Pharma Reaserch Prod Co Ltd's Strategic Asset Allocation Index has evolved across 10 annual periods from 2015 to 2024. As of March 2025, the index stands at 28.2%, representing strategic assets of ₩159.08 Billion against net assets of ₩564.31 Billion KRW. See 214450 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Pharma Reaserch Prod Co Ltd (2015–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Pharma Reaserch Prod Co Ltd from 2015 to 2024, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Pharma Reaserch Prod Co Ltd.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 25.9% | ₩147.31 Billion | ₩147.31 Billion | ₩- | ₩569.44 Billion | ▼ -0.8 pp |
| 2023 | 26.6% | ₩123.06 Billion | ₩123.06 Billion | ₩- | ₩462.19 Billion | ▼ -7.7 pp |
| 2022 | 34.3% | ₩117.96 Billion | ₩117.96 Billion | ₩- | ₩343.50 Billion | ▼ -1.5 pp |
| 2021 | 35.8% | ₩109.48 Billion | ₩109.48 Billion | ₩- | ₩305.44 Billion | ▼ -2.5 pp |
| 2020 | 38.3% | ₩94.05 Billion | ₩94.05 Billion | ₩- | ₩245.42 Billion | ▼ -15.8 pp |
| 2019 | 54.2% | ₩113.24 Billion | ₩73.89 Billion | ₩39.36 Billion | ₩209.07 Billion | ▲ +2.8 pp |
| 2018 | 51.3% | ₩101.47 Billion | ₩66.06 Billion | ₩35.40 Billion | ₩197.62 Billion | ▲ +12.0 pp |
| 2017 | 39.4% | ₩70.45 Billion | ₩27.18 Billion | ₩43.27 Billion | ₩178.85 Billion | ▲ +11.7 pp |
| 2016 | 27.7% | ₩47.50 Billion | ₩20.77 Billion | ₩26.73 Billion | ₩171.64 Billion | ▲ +7.0 pp |
| 2015 | 20.6% | ₩32.36 Billion | ₩20.40 Billion | ₩11.96 Billion | ₩156.75 Billion | — |